Exoskeleton Partial-Coated Stem Cells for Infarcted Myocardium Restoring

The integration of abiotic materials with live cells has emerged as an exciting strategy for the control of cellular functions. Exoskeletons consisting ofmetal-organic frameworks are generated to produce partial-coated bone marrow stem cells (BMSCs) to overcome low cell survival leading to disappointing effects for cell-based cardiac therapy. Partially coated exoskeletons can promote the survival of suspended BMSCs by integrating the support of exoskeletons and unimpaired cellular properties. In addition, partial exoskeletons exhibit protective effects against detrimental environmental conditions, including reactive oxygen species, pH changes, and osmotic pressure. The partial-coated cells exhibit increased intercellular adhesion forces to aggregate and adhere, promoting cell survival and preventing cell escape during cell therapy. The exoskeletons interact with cell surface receptors integrin alpha 5 beta 1, leading to augmented biological functions with profitable gene expression alteration, such as Vegfa, Cxcl12, and Adm. The partial-coated BMSCs display enhanced cell retention in infarcted myocardium through non-invasive intravenous injections. The repair of myocardial infarction has been achieved with improved cardiac function, myocardial angiogenesis, proliferation, and inhibition of cell apoptosis. This discovery advances the elucidation of potential molecular and cellular mechanisms for cell-exoskeleton interactions and benefits the rational design and manufacture of next-generation nanobiohybrids. Exoskeletons are generated to produce partial-coated bone marrow stem cells (BMSCs) as a novel biologic formulation with dual-sided characteristics. The exoskeleton side promotes cell viability and targeting, whereas the cell side retains the ability of cell adhesion and external secretion. With the synergism of increased survival, retention, and augmented paracrine secretion, the partial-coated BMSCs exhibit promising heart repair effects.image

Automated summary

The integration of metal-organic frameworks exoskeletons with bone marrow stem cells (BMSCs) improves cell survival and enhances cardiac repair. The partially coated cells are able to withstand detrimental environmental conditions and promote cell adhesion. The interaction between exoskeletons and cell surface receptors leads to altered gene expression and enhanced biological functions.